News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innogenetics (INGTF.PK) Grants Cervical Cancer Licence to GlaxoSmithKline (GSK)


7/2/2008 7:20:29 AM

BRUSSELS, July 1 (Reuters) - Belgian biotech company Innogenetics said on Tuesday it had granted GlaxoSmithKline a worldwide, non-exclusive license to use its technology in cervical cancer vaccine studies.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES